Development of contrast agents revolutionized the visualization of organs within the human body. With their inherent ability to bring discrete organs and tissues to investigational scrutiny, imaging agents have undergone immense changes. Technology developments over the last two decades have expanded application roles of imaging agents. Major imaging technologies that presently utilize imaging agents include - x-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), ultrasound technologies. X-ray contrast media is paving way for emerging segments such as MRI, Ultrasound and diagnostic radiopharmaceuticals. Reimbursement issues and procedural volumes are two key factors that exert a significant impact on market dynamics.
"Imaging Agents: A Global Strategic Business Report" provides a comprehensive review of market trends, drivers, challenges, product profile, players, competition, regulatory framework,
technological developments, research and development activity, recent developments, mergers, acquisitions, and other strategic industry activities. Analysis is presented for major
geographic markets such as United States, Japan, France, Germany, the UK, Italy, Asia, Latin America and the Middle East. Value analytics are provided in terms of product segments
including Contrast Media (X-ray imaging agents, MRI imaging agents and Ultrasound imaging agents) and Diagnostic Radiopharmaceuticals.
Demand for imaging agents moves in sync with diagnosis and management of several age-related diseases including cancer, cardiovascular disease, and neurological disease. United States is
the largest imaging agents market (http://www.strategyr.com/MCP-3336.asp) is the largest segment estimated at US$4.2
billion in 2007. The diagnostic radiopharmaceuticals market (www.strategyr.com/MCP-3336.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.StrategyR.com